期刊文献+

Expression and sub-cellular localization of leucine-rich repeats and immunoglobulin-like domains are related to antioxidant enzymes in human ependymoma and oligodendroglioma

Expression and sub-cellular localization of leucine-rich repeats and immunoglobulin-like domains are related to antioxidant enzymes in human ependymoma and oligodendroglioma
下载PDF
导出
摘要 The current study investigated correlations between the expression of leucine-rich repeats and immunoglobulin-like domain 1 (LRIG1) and antioxidant enzymes and related proteins, including manganese superoxide dismutase, glutamate cysteine ligase catalytic or regulatory subunit, thioredoxin and thioredoxin reductase, in both human ependymoma and oligodendroglioma. Results revealed that the cytoplasmic expression of LRIG1 was associated with expression of glutamate cysteine ligase catalytic subunit in the human ependymoma, while the nuclear expression of LRIG1 was associated with expression of thioredoxin reductase. In human oligodendroglioma, the cytoplasmic expression of LRIG1 was associated with expression of the glutamate cysteine ligase catalytic subunit. Both the nuclear and perinuclear expressions of LRIG1 were associated with expression of glutamate cysteine ligase regulatory subunit. These results indicated that several antioxidant enzymes and related proteins contributed to LRIG1 expression, and that these may participate in the antioxidation of the cells. The current study investigated correlations between the expression of leucine-rich repeats and immunoglobulin-like domain 1 (LRIG1) and antioxidant enzymes and related proteins, including manganese superoxide dismutase, glutamate cysteine ligase catalytic or regulatory subunit, thioredoxin and thioredoxin reductase, in both human ependymoma and oligodendroglioma. Results revealed that the cytoplasmic expression of LRIG1 was associated with expression of glutamate cysteine ligase catalytic subunit in the human ependymoma, while the nuclear expression of LRIG1 was associated with expression of thioredoxin reductase. In human oligodendroglioma, the cytoplasmic expression of LRIG1 was associated with expression of the glutamate cysteine ligase catalytic subunit. Both the nuclear and perinuclear expressions of LRIG1 were associated with expression of glutamate cysteine ligase regulatory subunit. These results indicated that several antioxidant enzymes and related proteins contributed to LRIG1 expression, and that these may participate in the antioxidation of the cells.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2011年第11期860-864,共5页 中国神经再生研究(英文版)
基金 the Swedish Institute, No. 00287/2006210 the North Sweden Cancer Foundation, Specialized Research Fund for the Doctoral Program New Teacher of Higher Education by the Chinese Ministry of Education, No. 200804861039 the National Natural Science Foundation of China, No. 30973073, 30973072
关键词 leucine-rich repeats and immunoglobulin-like domain 1 sub-cellular localization EPENDYMOMA OLIGODENDROGLIOMA antioxidant enzymes leucine-rich repeats and immunoglobulin-like domain 1 sub-cellular localization ependymoma oligodendroglioma antioxidant enzymes
  • 相关文献

参考文献29

  • 1Nilsson J,Vallbo C,Guo D,et al.Cloning,characterization,and expression of human LIG1.Biochem Biophys Res Commun.2001;284(5):1155-1161.
  • 2Holmlund C,Nilsson J,Guo D,et al.Characterization and tissue-specific expression of human LRIG2.Gene.2004;332:35-43.
  • 3Guo D,Holmlund C,Henriksson R,et al.The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea.Genomics.2004; 84(1):157-165.
  • 4Nilsson J,Starefeldt A,Henriksson R,et al.LRIG1 protein in human cells and tissues.Cell Tissue Res.2003;312(1):65-71.
  • 5Laederich MB,Funes-Duran M,Yen L,et al.The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.J Biol Chem.2004;279(45):47050-47056.
  • 6Gur G,Rubin C,Katz M,et al.LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.EMBO J.2004;23(16):3270-3281.
  • 7Shattuck DL,Miller JK,Laederich M,et al.LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.Mol Cell Biol.2007;27(5):1934-1946.
  • 8Ledda F,Bieraugel O,Fard SS,et al.Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation,downstream signaling,and biological responses to GDNF.J Neurosci.2008; 28(1):39-49.
  • 9Tanemura A,Nagasawa T,Inui S,et al.LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin:immunohistochemical analysis for 38 cases.Dermatol Surg.2005;31(4):423-430.
  • 10Guo D,Nilsson J,Haapasalo H,et al.Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumours.Acta Neuropathol (Berl).2006;111(3):238-246.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部